Nirmatrelvir
COVID-19 antiviral medicationMédicament antiviral
Nirmatrelvir is an antiviral medication developed by Pfizer which acts as an orally active 3C-like protease inhibitor. It is part of a nirmatrelvir/ritonavir combination used to treat COVID-19 and sold under the brand name Paxlovid.Le nirmatrelvir est un antiviral développé par le laboratoire pharmaceutique américain Pfizer agissant comme inhibiteur de protéase 3C-like des coronavirus.
